Assessment of the Global Market for CNS Therapeutics, 2022 – US Market is Projected to Reach $70 Billion by 2024 – ResearchAndMarkets.com

Assessment of the Global Market for CNS Therapeutics, 2022 – US Market is Projected to Reach Billion by 2024 – ResearchAndMarkets.com
CANNANNEW REPORT

DUBLIN–(BUSINESS WIRE)–The “CNS Therapeutics – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global CNS Therapeutics Market to Reach $132.1 Billion by 2024 Amid the COVID-19 crisis, the global market for CNS Therapeutics is projected to reach US$132.1 Billion by 2024, registering a compounded annual growth rate (CAGR) of 5.1% over the analysis period. The United States represents the largest regional market for CNS Therapeutics, accounting for an estimated 50.2% share of the global total. The market is projected to reach US$70 Billion by the end of the analysis period. China is expected to spearhead growth and emerge as the fastest growing regional market with a CAGR of 7.1% over the analysis period. The market is on a growth trajectory led by increasing incidence of CNS diseases, rapidly growing aging population, and rising healthcare expenditure. Unmet healthcare needs for detecting and treating CNS conditions brings to fore the untapped potential in the market. Presently, there exists increased demand for new laboratory tests to monitor CNS diseases and also an urgent requirement for developing safe and effective drugs that overthrow limitation of current generation drugs. Companies are therefore investing to develop novel drugs in the neurodegenerative segment. The industry has crossed some milestones in recent years with regard to developing therapies with relatively lesser side effects, convenient drug administration, and efficient performance, although major breakthroughs are still in pipeline. In addition to the reduction in prices in general as a result of patent expiries and the generication of the drugs market, the growing confidence in drug efficacy and clinical evidences is also offering a strong business case for these drugs. Greater patient compliance as a result of increased awareness about the benefits of the drugs, such as improved quality of life and reduction/prevention of disease co-morbidity, will…

Excerpt only …
READ MORE BELOW
Source : Assessment of the Global Market for CNS Therapeutics, 2022 – US Market is Projected to Reach Billion by 2024 – ResearchAndMarkets.com

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.